info@cytosynthesis.com
search

Science

Related
publications

  1. Lipoamino acid-based cerasomes for doxorubicin delivery: Preparation and in vitro evaluation. Gileva A.,Sarychev G., Kondrya M., Mironova U., Sapach A., Selina O., Budanova U., Burov S., Sebyakin Yu., Markvicheva E. // Materials Science & Engineering C, 2019, 100, 724–734.
  2. Metformin increases antitumor activity of MEK inhibitor binimetinib in2D and 3D models of human metastatic melanoma cells. Ryabaya O., Prokofieva A., Akasov R., Khochenkov D., Emelyanova M., Burov S., Markvicheva E., Inshakov A., Stepanova E. // Biomedicine & Pharmacotherapy, 2019, 109, 2548-2560. DOI: 10.1016/j.biopha.2018.11.109.
  3. Functionalized Folic Acid-Conjugated Amphiphilic Alternating Copolymer Actively Targets 3D Multicellular Tumour Spheroids and Delivers the Hydrophobic Drug to the Inner Core. Li X., Sambi M., DeCarlo A., Burov S.V., Akasov R., Markvicheva E., Malardier-Jugroot C., Szewczuk M.R. // Nanomaterials (Basel), 2018, 8(8). pii: E588. DOI: 10.3390/nano8080588.
  4. Novel Doxorubicin Derivatives: Synthesis and Cytotoxicity Study in 2D and 3D in Vitro Models. Akasov R., Drozdova M., Zaytseva-Zotova D., Leko M., Chelushkin P., Marc A., Chevalot I., Burov S., Klyachko N., Vandamme T., Markvicheva E. // Adv Pharm Bull, 2017, 7(4), 593–601 DOI: 10.15171/apb.2017.071.
  5. Sialylation facilitates self-assembly of 3D multicellular prostaspheres by using cyclo-RGDfK(TPP) peptide. Haq S., Samuel V., Haxho F., Akasov R., Leko M., Burov S.V., Markvicheva E., Szewczuk M.R. // Onco Targets Ther. 2017. V. 10. P. 2427–2447. DOI: 10.2147/OTT.S133563.
  6. 3D in vitro co-culture models based on normal cells and tumor spheroids formed by cyclic RGD-peptide induced cell self-assembly. Akasov R., Gileva A., Zaytseva- Zotova D., Burov S., Chevalot I., Guedon E., Markvicheva E. // Biotechnology Letters. 2017. V. 39. N 1. P. 45-53. DOI: 10.1007/s10529-016-2218-9.
  7. Sialylation transmogrifies human breast and pancreatic cancer cells into 3D multicellular tumor spheroids using cyclic RGD-peptide induced self-assembly. Szewczuk M., Akasov R., Haq S., Haxho F., Samuel V., Burov S., Markvicheva E., Neufeld R. // Oncotarget. 2016. V. 7. N 40. P. 66119-66134. DOI: 10.18632/oncotarget.11868.
  8. Formation of multicellular tumor spheroids induced by cyclic RGD-peptides and use for anticancer drug testing in vitro. Akasov R., Zaytseva-Zotova D., Burov S., Leko M., Dontenwill M., Chiper M., Vandamme T., Markvicheva E. // Int. J. Pharm. 2016. V. 506. P. 148-157. doi: 10.1016/j.ijpharm.2016.04.005.
  9. Convenient method of peptide hydrazide synthesis using a new hydrazone resin. Chelushkin P.S., Polyanichko K.V., Leko M.V., DoroshM.Yu., Bruckdorfer T., Burov S.V. // Tetrahedron Lett. 2015. V. 56. N 4. P. 619-622.
  10. Ultrasonically assisted polysaccharide microcontainers for delivery of lipophilic antitumor drugs: preparation and in vitro evaluation. Akasov R., Borodina T., Zaytseva E., Sumina A., Bukreeva T., Burov S., Markvicheva E. // ACS Appl. Mater. Interfaces. 2015. V. 7. N 30. P. 16581-16589. doi: 10.1021/acsami.5b04141.
  11. Creatinyl amino acids – new hybrid compounds with neuroprotective activity. Burov S.V., Leko M.V., DoroshM.Yu., Dobrodumov A.V., Veselkina O.S. // J. Pept. Sci. 2011. V. 17. N. 9. P. 620-626.
  12. In vivo neuroprotection by a creatine-derived compound: Phosphocreatine–Mg-complex acetate. Perasso L., Adriano E., Ruggeri P., Burov S.V., Gandolfo C., Balestrino M. // Brain Research. 2009. V. 1285. N 18. P. 158-163.
  13. Protective effects of some creatine derivatives in brain tissue anoxia. Perasso L., Lunardi G.L., Risso F., Pohvozcheva A.V., Leko M.V., Gandolfo C., Florio T., Cupello A., Burov S.V., Balestrino M. // Neurochem. Res. 2008. V. 33. N 5. P. 765-775.
  14. The creatine transporter mediates the uptake of creatine by brain tissue, but not the uptake of two creatine-derived compounds. Lunardi G., Parodi A., Perasso L., Pohvozcheva A.V., Scarrone S., Adriano E., Florio T., Gandolfo C., Cupello A., Burov S.V., Balestrino M. // Neuroscience. 2006. V. 142. N 4. P. 991-997.
  15. Complexes of plasmid DNA with basic domain 47-57 of the HIV-1 Tat protein are transferred to mammalian cells by endocytosis-mediated pathways. Ignatovich I.A., Dizhe E.B., Pavlotskaya A.V., Akifiev B.N., Burov S.V., Orlov S.V., Perevozchikov A.P. // J. Biol. Chem. 2003, V. 278, N 43, P. 42625-42636.

International
patents

  1. Burov S., Epstein N. Peptides useful for treating GnRH associated diseases. WO 2005/116058 A1. Priority date 27 May 2004.
  2. Balestrino M., Burov S.V., Lensman M., Polenov S., and Yakutseni P.P., Complessi di fosfocreatina, Italian Patent Application TO2005A000847 of November 30, 2005.
  3. Balestrino Maurizio, Burov Sergey, Lensman Michael,Polenov Sergey, Yakutseni Pavel. Phosphocreatine complexes. WO/2007/063509. Publication Date: 07.06.2007.
  4. Burov S.V., Khromov A.N. Creatine amides, a method for the production thereof and an agent exhibiting a neuroprotective action.WO/2010/074591. Publication date: 01.07.2010.
  5. Burov S.V., Veselkina O.S., Leko M.V. Process for preparing creatine amides. WO/2011/056091. Priority Date: 03.11.2009. Publication Date: 12.05.2011.
Close